Editorial Commentary : Platelet‐Rich Plasma Improves Arthroscopic Rotator Cuff Repair Outcomes but Not as Much as We Would Like

Abstract Biologic optimization of rotator cuff tears is perhaps the next frontier for improving outcomes after arthroscopic repair. A lack of clarity regarding multiple variables when it comes to platelet‐rich plasma formulation and application limits the usefulness of these products. Recent literature helps provide clarity. Optimization of platelet‐rich plasma with leukocyte‐poor formulations while maximizing platelet concentration, along with intratendinous insertion, appears to be the best practice for improving retear rates and patient‐reported outcomes. Although the improvements are not clinically substantial, we now have a pathway to attain meaningful clinical results with biologic augmentation.